NOMAD Power Solutions, Inc.(NMAD)

Biotechnology · Boca Raton, FL

$4.25+0.24 (+5.87%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:42:36.913Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:42:36.913Z.

Quote observation: 2026-10-06T19:40:12.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 52,539,399
Total debt · period ending 2026-06-30: 1,101
Cash · period ending 2026-06-30: 12,670
TTM operating EBITDA · period ending 2026-06-30: -5,498,151

FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NMAD EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

NMAD Competitors' EV/EBITDA Ratio

NMAD

NOMAD Power Solutions, Inc.

Current

Market Cap

$52.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZYBT

Zhengye Biotechnology Holding Limited

vs NMAD

Market Cap

$52.60M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs NMAD

Market Cap

$53.11M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs NMAD

Market Cap

$53.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs NMAD

Market Cap

$53.15M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs NMAD

Market Cap

$53.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs NMAD

Market Cap

$51.61M

EV/EBITDA Ratio

9.09x

TTM Avg

5.34x

3Y Avg

6.36x

5Y Avg

5.55x

COCH

Envoy Medical, Inc.

vs NMAD

Market Cap

$50.99M

EV/EBITDA Ratio

N/A

TTM Avg

335.70x

3Y Avg

335.70x

5Y Avg

335.70x

IMA

ImageneBio Inc

vs NMAD

Market Cap

$53.24M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs NMAD

Market Cap

$51.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
NOMAD Power Solutions, Inc. (NMAD)	$52.54M	N/A	N/A	N/A	N/A
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.60M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.11M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$53.81M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$53.15M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$53.46M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	9.09x	5.34x	6.36x	5.55x
Envoy Medical, Inc. (COCH)vs ›	$50.99M	N/A	335.70x	335.70x	335.70x
ImageneBio Inc (IMA)vs ›	$53.24M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.51M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics